Basic Information
Revance Therapeutics, Inc. is a biopharmaceutical company dedicated to the development and commercialization of products and treatments for dermatology and aesthetic applications. Its product portfolio includes RT001, a botulinum toxin type A (BoNT-A) designed for physician-administered use in aesthetic procedures, hyperhidrosis, and dermatological indications.
Revance Therapeutics, Inc.
Nashville,Tennessee,United States of America
101~500 people
January 01, 2002
info@revance.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios